Topics

Study of Brain Efficacy and Reorganization After Combined Donepezil Treatment, Intensive Rehabilitation and Transcranial Direct Current Stimulation in Post-stroke Chronic Aphasia

2019-10-28 13:57:25 | BioPortfolio

Summary

Post-stroke aphasia (PSA), the partial or total loss of the ability to produce and/or understand language associated with stroke, is a highly prevalent and disabling disorder that negatively impacts the personal, social and working life of patients and families. Modern theory-based language therapies (LT) with proved efficacy in chronic PSA are brief (weeks), intensive, and oriented to specific domains (e.g., anomia). However, in order to maximize therapeutic benefits, it becomes essential to implement complementary strategies that boost gains in language, communication and behaviour and also to identify predictors of treatment response (demographics, anatomical) that enable to customize interventions adjusting them to each profile (linguistic deficits, brain structure and connectivity). Our group has repeatedly showed that LT combined with cognitive enhancing drugs (CED) (e.g., Donepezil and Memantine) are safe and promote better outcomes that when these interventions are administered separately. Moreover, non-invasive brain stimulation (NIBS) is also emerging as a promising treatment for chronic PSA. However, is still unknown whether or not treatments that combine several biological strategies aid to improve outcomes further. Brain changes induced by these interventions and the premorbid characteristic of a "good responder" are also unknown. The aims of this clinical trial are: (1) Study the efficacy of combined treatments in a sample of patients with chronic PSA (n = 40); (2) Document with multimodal neuroimaging the functional and connectivity changes (neuroplasticity) promoted by these interventions; and (3) Identify linguistic, cognitive, behavioural, and neuroimaging variables that may predict outcomes for each intervention.

Description

Aphasia is a devastating disorder involving total or partial loss of language. It can affect all communicative, expressive, and receptive modalities, including language production, comprehension, reading, writing, and the ability to gesture. Stroke is the most common cause of aphasia. In Europe the annual incidence of stroke is high, varying between 318 and 372 cases in men and between 195 and 240 in women per 100,000 inhabitants. In Spain it is the second cause of death and the first in women, affecting approximately 130,000 people every year. Between 21 and 38% of these cases present post-stroke aphasia (PSA) in the acute stage. PSA is associated with high morbidity and mortality, and only 20% of those affected recover spontaneously. Consequently, the PSA is very frequent and evolves to chronicity in most patients. There are different subtypes of aphasia depending on the linguistic profile. A distinction is made between aphasia with preserved repetition and aphasia with altered repetition. The first group includes transcortical aphasias (sensory, motor and mixed) and anomic aphasias, and the second, in order of severity, global aphasias, Wernicke aphasias, Broca aphasias, and conduction aphasias (CA). The latter group is associated with perisylvian lesions and are most frequent (>80% of cases). Aphasias in the first 2-3 months tend to evolve into less severe profiles, so that Broca and Wernicke aphasias can, in chronic stages, progress to CA. Aphasia has a negative impact on the affected person and their family members, reducing work, personal, affective and social life. It is accompanied by high health and social expenditure, since one third of patients are under 65 years of age and, due to the inability to communicate, they cannot return to work, generating a burden on the family caregivers with the economic and health costs that this entails. For this reason, the implementation of strategies aimed at improving aphasia, communication, associated emotional disorders and the quality of life of patients and carers is crucial for those affected to achieve autonomy, allowing them to return to work and prevent additional cognitive impairment in elderly patients. Currently, the most popular PSA rehabilitation therapies are: speech rehabilitation therapies, drugs and, more recently, non-invasive neurostimulation techniques.

1. Speech therapies Speech therapy is the treatment of choice in aphasia. The most commonly used is conventional or standard therapy where a specific strategy (description of pictures, repetition of words or phrases, answers to questions) is employed depending on the patient's deficits. They are usually applied 2 or 3 times a week with a duration of 30-45 minutes per session. However, some of the problems with these therapies are their prolonged duration (several years) and, consequently, their high cost, which limits their applicability in Public Health Services. In addition, the logistical limitations (difficulty of transport, shortage of staff) of the treatment centres prevent the administration of the minimum of 2 hours per week of therapy required to obtain clinically relevant benefits. On the other hand, the benefits obtained are insufficient and the progress made decreases once the treatment has been abandoned. For this reason, during the last two decades, speech therapies have been designed in which short (2 weeks) but very intensive (3 hours per day) rehabilitation exercises based on neuroscientific evidence are applied which effectively solve the limitations of traditional therapies. In this sense, Intensive Language-Action Therapy (ILAT) administered for two consecutive weeks (3 hours/day for 2 weeks - 30 hours of treatment -) has gained worldwide acceptance as it is significantly more effective than traditional rehabilitation techniques even when the total therapy time (2 hours/week for 15 weeks - 30 hours of treatment) is the same. In addition, the benefits achieved with ILAT in 2 weeks are maintained for 6 months after completion of treatment. ILAT is a group rehabilitation therapy (2 or 3 participants) that employs a play dynamic among participants, and its ILAT-plus modality also reinforces the training of specific language skills (e.g., repetition).

2. Pharmacological interventions LT is effective in the PSA, even in chronic stages (> 6 months after stroke). However, in many patients with moderate and severe aphasia the benefits of LT are limited (e.g., partial recovery of verbal fluency and auditory comprehension).These limitations have led to the use of other, more effective interventions to treat PSA. Several clinical trials in patients with acute and chronic PSAs conducted in the last decade have shown that the benefits achieved with rehabilitation can be significantly increased when these therapies are combined with drugs. Several pharmacological agents (Levodopa, Bromocriptine, Piracetam, Amantadine, Dexamfetamine, and others) have been used with variable results. However, several controlled clinical trials have found significant improvements in production deficits, understanding, and in the overall severity of aphasia in patients with PSAs treated with Piracetam, Donepezil, Galantamine, or Memantine.

The theoretical justification underpinning pharmacological therapies in the treatment of PSA is that brain lesions (focal or diffuse) interrupt the projection of the main neurotransmitter systems (acetylcholine, dopamine, serotonin, noradrenaline), causing synaptic depression both in perilesional zones and in distant zones of both cerebral hemispheres and the cerebellum that are connected to the injured area. The administration of drugs induces the restoration of physiological activity of partially damaged neurotransmission circuits by favoring neural plasticity and long-term potentiation (underlying mechanism of memory and learning). In PSA rehabilitation, biological and behavioral treatments strengthen the activity of perilesional regions and brain areas that previously did not perform language functions, but that after stroke are recruited vicariously increasing the ability of language recovery in the patient with PSA. In the last decade, it has been shown that the acetylcholinesterase inhibitor (an enzyme that degrades acetylcholine) Donepezil, and the NMDA receptor antagonist Memantine (antidementia drugs with a good safety/tolerability profile) are more effective than placebo in the treatment of PSA, especially when these are prescribed in association with rehabilitation techniques based on neuroscientific evidence.

3. Neurostimulation Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that induces changes in the excitability of brain tissue by increasing (anodal stimulation, A-tDCS) or decreasing (cathodal stimulation, C-tDCS) the activity of nerve cells by applying weak electrical currents. The theoretical justification for the use of tDCS as an adjuvant technique in PSA rehabilitation is based on the fact that it modulates (increases or decreases) the rate of neuronal discharge, presumably through changes in the resting potential of the membrane, and thus facilitates or hinders the functioning of connections between neuronal groups. tDCS has been shown to be effective in a variety of neurological and psychiatric disorders and has several advantages over other stimulation techniques, e.g. transcranial magnetic stimulation: better safety profile, easy to use, well tolerated by patients and better cost-benefit ratio. Increasingly, studies indicate that tDCS has beneficial effects on language deficits (verbal fluency, naming, grammatical decision) in people with PSA. In addition, when applied in conjunction with ST, it enhances the benefits obtained with PSA. Benefits have been described in patients with PSA using very varied stimulation parameters (intensity, type, duration, brain area), each with different theoretical justification. The main modalities are (1) anodal stimulation (A-tDCS; excitatory) of perilesional areas with the aim of promoting the recovery of brain tissue surrounding the lesion; (2) cathodal stimulation (C-tDCS inhibitory stimulation of healthy regions interfering with recovery); (3) A-tDCS on areas of the healthy hemisphere to increase activity and facilitate the reorganization of functions that previously depended on injured areas of the left hemisphere. tDCS is a technique that has been shown to be effective, although more studies are needed in patients with PSA leading to the identification of the most suitable stimulation parameters, the location and extent of the lesion and the previous brain structure of each patient, and to determine the added value that this technique provides in combination therapies.

Justification and project contributions Intensive ST, neurostimulation and pharmacological interventions have independently been shown to be effective in the rehabilitation of PSA. Previous work indicates that combination therapies (ILAT and drug therapy) are superior to other treatment options as they enhance synergistic mechanisms that promote improved learning, language and functional communication in affected individuals. However, more research is needed to explore the benefits of combination therapies (e.g. Donepezil, ILAT and tDCS) and to identify the mechanisms and structures that are modulated by each of these rehabilitation therapies and that mediate recovery, with the aim of establishing response predictors.

The aim of the current project is to evaluate the efficacy of ILATplus (ILAT + repetition/imitation training) (3 hours/day for 2 consecutive weeks, total = 30 hours) combined with Donepezil and tDCS in the treatment of cognitive deficits in patients with chronic post-stroke CA and other aphasias with repetition impairment (Broca's like CA and Wernicke's like CA). The main deficit of CA (impaired verbal repetition) is common to all perisylvian aphasias, and constitutes an important rehabilitation goal, so the benefits observed can be extrapolated to other subtypes of aphasia.

Through the use of different neuroimaging techniques, the investigators seek to identify anatomical and functional changes that are related to the benefits observed after interventions, and analyze the role of the uninjured (right) hemisphere in recovery. The analysis of behavioral and neuroimaging data will allow us to identify possible predictors (demographic, structural, functional) of response.

The investigators hope that the results derived from this clinical trial will have a positive impact reflected in several aspects. This study may show for the first time the potential superiority of combined therapies (ILATplus/Donepezil/tDCS) over other treatment options. The analysis of the results, in combination with the findings of previous studies will allow to optimize the rehabilitation of the PSA with short intensive group therapies (ILAT) and consequently, more ecological and less expensive compared to the current rehabilitation strategies that use prolonged therapies generally with little efficacy. In addition, the results of this study will make it possible to identify patients who will benefit from this type of intervention based on anatomical and demographic predictors of response to treatment, and thereby improve their success.

Finally, this project will be carried out by a multi-disciplinary group with extensive scientific and technical experience in this line of research. The methodology to be used, as well as the potential results, are based on the progress achieved by basic neuroscientific research with translational impact on the neurorehabilitation of language alterations associated with stroke.

Study Design

Conditions

Aphasia

Intervention

Donepezil, Intensive-Language Action Therapy, Transcranial direct current stimulation

Location

Centro de Investigaciones Medico-Sanitarias. University of Malaga
Málaga
Spain
29010

Status

Recruiting

Source

University of Malaga

Results (where available)

View Results

Links

Published on BioPortfolio: 2019-10-28T13:57:25-0400

Clinical Trials [2593 Associated Clinical Trials listed on BioPortfolio]

Transcranial Direct Current Stimulation (tDCS) and Intensive Therapy in Aphasia

Intensive therapy for aphasia has been demonstrated to improve language functioning after stroke or other neurological injury. However, recovery is generally not complete and new therapies...

Transcranial Direct Current Stimulation (tDCS) and Spaced Aphasia Treatment

The purpose of this study is to assess changes in language abilities of participants with chronic, post-stroke aphasia following an 8-week therapy period combined with brain stimulation. W...

Effects of Transcranial Direct Current Stimulation (tDCS) on Language

This study will investigate the effects of mild electrical stimulation in conjunction with speech therapy for people with post-stroke aphasia to enhance language recovery.

Combining Language Therapy With rTMS in Aphasia

With the present RCT, the investigators aimed at finding an optimal protocol for the neurorehabilitation of chronic post-stroke aphasia by combining two promising methods, ILAT (Intensive ...

Transcranial Direct Current Stimulation to Enhance Training Effectiveness in Chronic Post-Stroke Aphasia

The aim of the study is to investigate whether intensive speech-language therapy (SLT) combined with anodal transcranial direct current stimulation (tDCS) leads to better communication per...

PubMed Articles [25516 Associated PubMed Articles listed on BioPortfolio]

Reductions in GABA following a tDCS-language intervention for primary progressive aphasia.

Transcranial direct current stimulation (tDCS) has shown efficacy in augmenting the effects of language therapy in primary progressive aphasia (PPA). The mechanism of action of tDCS is not understood,...

Exploring the effects of Transcranial Direct Current Stimulation over the prefrontal cortex on working memory: a cluster analysis approach.

The interest in the use of anodal transcranial direct current stimulation (tDCS) for the enhancement of cognitive functioning has increased significantly in recent years. However, the efficacy of this...

The effects of transcranial direct current stimulation compared to standard bupropion for the treatment of tobacco dependence: A randomized sham-controlled trial.

Current treatments for smoking cessation are not effective for most smokers. This study aims to examine the effectiveness of transcranial Direct Current Stimulation (tDCS) on smoking cessation.

The efficacy of transcranial direct current stimulation and transcranial magnetic stimulation for chronic orofacial pain: A systematic review.

Transcranial Direct Current Stimulation (tDCS) and Transcranial Magnetic Stimulation (TMS) have been described as promising alternatives to treat different pain syndromes. This study evaluated the eff...

Transcranial direct current stimulation for the treatment of generalized anxiety disorder: A randomized clinical trial.

Generalized anxiety disorder (GAD) is a common condition with current treatments being only moderately effective. Non-invasive brain stimulation techniques might provide a novel approach for treating ...

Medical and Biotech [MESH] Definitions

A technique of brain electric stimulation therapy which uses constant, low current delivered via ELECTRODES placed on various locations on the scalp.

Rehabilitation of persons with language disorders or training of children with language development disorders.

Removal of tissue with electrical current delivered via electrodes positioned at the distal end of a catheter. Energy sources are commonly direct current (DC-shock) or alternating current at radiofrequencies (usually 750 kHz). The technique is used most often to ablate the AV junction and/or accessory pathways in order to interrupt AV conduction and produce AV block in the treatment of various tachyarrhythmias.

Computer processing of a language with rules that reflect and describe current usage rather than prescribed usage.

Application of electric current in treatment without the generation of perceptible heat. It includes electric stimulation of nerves or muscles, passage of current into the body, or use of interrupted current of low intensity to raise the threshold of the skin to pain.

More From BioPortfolio on "Study of Brain Efficacy and Reorganization After Combined Donepezil Treatment, Intensive Rehabilitation and Transcranial Direct Current Stimulation in Post-stroke Chronic Aphasia"

Quick Search

Relevant Topics

Stroke - Cerebrovascular Disease (CVA)
A stroke is a serious medical condition that occurs when the blood supply to part of the brain is cut off. Strokes are a medical emergency and prompt treatment is essential because the sooner a person receives treatment for a stroke, the less damage is ...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Complementary and Alternative Medicine
Alternative medicine are whole medical systems that did not fit with conventional medicine as they have completely different philosophies and ideas on the causes of disease, methods of diagnosis and approaches to treatment. Although often overlapping, co...


Searches Linking to this Trial